MERKEL CELL CARCINOMA OF SKIN
Clinical trials for MERKEL CELL CARCINOMA OF SKIN explained in plain language.
Never miss a new study
Get alerted when new MERKEL CELL CARCINOMA OF SKIN trials appear
Sign up with your email to follow new studies for MERKEL CELL CARCINOMA OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to shrink skin tumors before surgery
Disease control OngoingThis early-stage trial tests a drug called PH-762, injected directly into skin tumors, for people with squamous cell carcinoma, melanoma, or Merkel cell carcinoma. Participants receive four weekly injections into one tumor, then have it surgically removed about two weeks later. T…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Phase: PHASE1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a simple blood test predict skin cancer outcomes?
Knowledge-focused OngoingThis study looks at blood samples from 20 adults with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long someone lives. Researchers will compare these markers to standard measures like tumor response and survival…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC